Search results
Results from the WOW.Com Content Network
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, wholly owned by the Swiss multinational pharmaceutical company, the Roche Group. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. [6]
He is recipient of the 1990 National Medal of Science, co-recipient of the 1996 Lemelson–MIT Prize, and a co-founder of Genentech. He was professor at the University of California, San Francisco (UCSF) and later served as vice president of Genentech from 1976 until his retirement in 1991.
Robert "Bob" Swanson (1947–1999) was an American venture capitalist who co-founded Genentech in 1976 with Herbert Boyer. Genentech is one of the leading biotechnology companies in the world. He was CEO of Genentech from 1976 to 1990, and chairman from 1990 to 1996.
In 1976 Genentech, the first genetic engineering company was founded by Herbert Boyer and Robert Swanson and a year later the company produced a human protein (somatostatin) in E.coli. Genentech announced the production of genetically engineered human insulin in 1978. [75] In 1980 the U.S. Supreme Court in the Diamond v.
William Anderson (born August 23, 1966) is an American business executive who has been the chief executive officer (CEO) of Bayer AG since June 2023. [1] [2]Prior to his current role, Anderson was CEO of Genentech from 2017 to 2018, and later CEO of the Roche's Pharmaceuticals Division from 2019 to 2022.
Stanley Norman Cohen (born February 17, 1935) is an American geneticist [2] and the Kwoh-Ting Li Professor in the Stanford University School of Medicine. [3] Stanley Cohen and Herbert Boyer were the first scientists to transplant genes from one living organism to another, a fundamental discovery for genetical engineering.
In 1993, Francis joined Genentech, Inc., of South San Francisco to try to develop a vaccine for HIV. In 1995, Francis and fellow retro-virologist Dr. Robert Nowinski spun off Genentech's HIV vaccine unit after the company had disappointing results, and founded VaxGen, based in Brisbane, California, to continue working on vaccines. After the ...
Together with Steve McKnight and Robert Tjian, he founded Tularik in 1991, and was their president and CEO until Tularik was acquired by Amgen for $1.3 billion in 2004. [3] Goeddel earned his bachelor's degree in chemistry from the University of California, San Diego, and his PhD in biochemistry from the University of Colorado, Boulder.